View in EDS PDF Full Text

Targeting Fn14 as a therapeutic target for cachexia reprograms the glycolytic pathway in tumour and brain in mice.

Saved in:
Bibliographic Details
Title: Targeting Fn14 as a therapeutic target for cachexia reprograms the glycolytic pathway in tumour and brain in mice.
Authors: Burvenich IJG; Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, 145 Studley Road, Melbourne, Heidelberg, VIC, 3084, Australia.; School of Cancer Medicine, La Trobe University, Melbourne, VIC, 3086, Australia., Osellame LD; Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, 145 Studley Road, Melbourne, Heidelberg, VIC, 3084, Australia.; School of Cancer Medicine, La Trobe University, Melbourne, VIC, 3086, Australia.; Department of Biochemistry and Genetics, La Trobe Institute for Molecular Science, La Trobe University, Melbourne, VIC, 3083, Australia., Rigopoulos A; Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, 145 Studley Road, Melbourne, Heidelberg, VIC, 3084, Australia., Huynh N; Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, 145 Studley Road, Melbourne, Heidelberg, VIC, 3084, Australia.; School of Cancer Medicine, La Trobe University, Melbourne, VIC, 3086, Australia., Cao Z; Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, 145 Studley Road, Melbourne, Heidelberg, VIC, 3084, Australia.; School of Cancer Medicine, La Trobe University, Melbourne, VIC, 3086, Australia.; Department of Molecular Imaging and Therapy, Austin Health, Melbourne, VIC, 3083, Australia., Hoogenraad NJ; Department of Biochemistry and Genetics, La Trobe Institute for Molecular Science, La Trobe University, Melbourne, VIC, 3083, Australia., Scott AM; Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, 145 Studley Road, Melbourne, Heidelberg, VIC, 3084, Australia. andrew.scott@onjcri.org.au.; School of Cancer Medicine, La Trobe University, Melbourne, VIC, 3086, Australia. andrew.scott@onjcri.org.au.; Department of Molecular Imaging and Therapy, Austin Health, Melbourne, VIC, 3083, Australia. andrew.scott@onjcri.org.au.; Department of Medicine, University of Melbourne, Melbourne, VIC, 3052, Australia. andrew.scott@onjcri.org.au.
Source: European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2024 Nov; Vol. 51 (13), pp. 3854-3862. Date of Electronic Publication: 2024 Jul 26.
Publication Type: Journal Article
Journal Info: Publisher: Springer-Verlag Berlin Country of Publication: Germany NLM ID: 101140988 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1619-7089 (Electronic) Linking ISSN: 16197070 NLM ISO Abbreviation: Eur J Nucl Med Mol Imaging Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39060375
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Targeting Fn14 as a therapeutic target for cachexia reprograms the glycolytic pathway in tumour and brain in mice.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Burvenich+IJG%22">Burvenich IJG</searchLink>; Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, 145 Studley Road, Melbourne, Heidelberg, VIC, 3084, Australia.; School of Cancer Medicine, La Trobe University, Melbourne, VIC, 3086, Australia.<br /><searchLink fieldCode="AU" term="%22Osellame+LD%22">Osellame LD</searchLink>; Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, 145 Studley Road, Melbourne, Heidelberg, VIC, 3084, Australia.; School of Cancer Medicine, La Trobe University, Melbourne, VIC, 3086, Australia.; Department of Biochemistry and Genetics, La Trobe Institute for Molecular Science, La Trobe University, Melbourne, VIC, 3083, Australia.<br /><searchLink fieldCode="AU" term="%22Rigopoulos+A%22">Rigopoulos A</searchLink>; Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, 145 Studley Road, Melbourne, Heidelberg, VIC, 3084, Australia.<br /><searchLink fieldCode="AU" term="%22Huynh+N%22">Huynh N</searchLink>; Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, 145 Studley Road, Melbourne, Heidelberg, VIC, 3084, Australia.; School of Cancer Medicine, La Trobe University, Melbourne, VIC, 3086, Australia.<br /><searchLink fieldCode="AU" term="%22Cao+Z%22">Cao Z</searchLink>; Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, 145 Studley Road, Melbourne, Heidelberg, VIC, 3084, Australia.; School of Cancer Medicine, La Trobe University, Melbourne, VIC, 3086, Australia.; Department of Molecular Imaging and Therapy, Austin Health, Melbourne, VIC, 3083, Australia.<br /><searchLink fieldCode="AU" term="%22Hoogenraad+NJ%22">Hoogenraad NJ</searchLink>; Department of Biochemistry and Genetics, La Trobe Institute for Molecular Science, La Trobe University, Melbourne, VIC, 3083, Australia.<br /><searchLink fieldCode="AU" term="%22Scott+AM%22">Scott AM</searchLink>; Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, 145 Studley Road, Melbourne, Heidelberg, VIC, 3084, Australia. andrew.scott@onjcri.org.au.; School of Cancer Medicine, La Trobe University, Melbourne, VIC, 3086, Australia. andrew.scott@onjcri.org.au.; Department of Molecular Imaging and Therapy, Austin Health, Melbourne, VIC, 3083, Australia. andrew.scott@onjcri.org.au.; Department of Medicine, University of Melbourne, Melbourne, VIC, 3052, Australia. andrew.scott@onjcri.org.au.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101140988%22">European journal of nuclear medicine and molecular imaging</searchLink> [Eur J Nucl Med Mol Imaging] 2024 Nov; Vol. 51 (13), pp. 3854-3862. <i>Date of Electronic Publication: </i>2024 Jul 26.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer-Verlag+Berlin%22">Springer-Verlag Berlin </searchLink><i>Country of Publication: </i>Germany <i>NLM ID: </i>101140988 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1619-7089 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216197070%22">16197070 </searchLink><i>NLM ISO Abbreviation: </i>Eur J Nucl Med Mol Imaging <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39060375
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s00259-024-06836-1
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 3854
    Titles:
      – TitleFull: Targeting Fn14 as a therapeutic target for cachexia reprograms the glycolytic pathway in tumour and brain in mice.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Burvenich IJG
      – PersonEntity:
          Name:
            NameFull: Osellame LD
      – PersonEntity:
          Name:
            NameFull: Rigopoulos A
      – PersonEntity:
          Name:
            NameFull: Huynh N
      – PersonEntity:
          Name:
            NameFull: Cao Z
      – PersonEntity:
          Name:
            NameFull: Hoogenraad NJ
      – PersonEntity:
          Name:
            NameFull: Scott AM
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 11
              Text: 2024 Nov
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 1619-7089
          Numbering:
            – Type: volume
              Value: 51
            – Type: issue
              Value: 13
          Titles:
            – TitleFull: European journal of nuclear medicine and molecular imaging
              Type: main
ResultId 1